Prévisions

Aucune donnée d'analyste n'est disponible pour cette entreprise.

Actualités Accéder au fil d'actualités

Mydecine Innovations Group reports quarterly earnings per share of CAD 0.09

Mydecine Innovations Group released results for the quarter ended September 30, 2025, reporting earnings per share of CAD 0.09. In the same quarter last year the company reported a loss of CAD 1,500 per share. No further financial details were disclosed in the release. » Plus sur finanzen.net